NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.13 in the quarter versus EPS of $0.08 in the year-earlier quarter. Revenue Decreased 31.78% to $36.51 million from the year-earlier quarter.
NPS Pharmaceuticals, Inc. reported adjusted EPS loss of $0.13 per share. By that measure, the company missed the mean analyst estimate of $-0.07. It beat the average revenue estimate of $31.62 million.